Aridis Pharmaceuticals Inc (ARDS)

0.059 +0.005 (+10.28%)
Close USD Disclaimer

Aridis Pharmaceuticals Inc Company Profile

Equity Type
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin, as well as developing AR-301 as an adjunctive therapy with SOC antibiotics to treat hospital acquired pneumonia and ventilator associated pneumonia. The company is also developing AR-320, a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin to treat infections caused by methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus; AR 501, an inhaled gallium citrate, which is in Phase 1/2a for the treatment of chronic lung infection associated with cystic fibrosis; and AR-101, a human IgM mAb, which is in Phase II clinical trials targeting Pseudomonas aeruginosa liposaccharides serotype O11. In addition, it develops AR-401 that is in preclinical stage to treat infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-701, a cocktail of two fully human immunoglobulin 1. The company was founded in 2003 and is headquartered in Los Gatos, California.
Contact Information
Los Gatos,95032 United States
408 385 1742
408 356 9548
Top Executives
Steven Michael Opal 0 0000 Member Scientific Advisory Board
John F. Hamilton 78 2015 Independent Director
Jean Chastre 0 2016 Member of Clinical Advisory Board
Bruno Francois 0 2016 Member of Clinical Advisory Board
John S. Patton 75 0000 Member of the Scientific Advisory Board
Alan H. Cohen 62 2017 Member of Clinical Advisory Board
Marin H. Kollef 66 2016 Member of Clinical Advisory Board
Jerry Pier 0 0000 Member of the Scientific Advisory Board
David Salisbury 0 2019 Member of Scientific Advisory Board
Harry B. Greenberg 0 0000 Member of Scientific Advisory Board
Susan R. Windham-Bannister 72 2019 Independent Director
Vu L. Truong 59 2003 Founder, CEO, Chief Scientific Officer & Director
Eric J. Patzer 74 2003 Founder & Executive Chairman
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles